Ublituximab Under Review for Relapsing Forms of Multiple Sclerosis
Ublituximab is an investigational glycoengineered monoclonal antibody that targets CD20.
Multiple Sclerosis
Lyvispah Oral Granules Approved for Spasticity Due to Multiple Sclerosis
Lyvispah is supplied as a strawberry-flavored, dissolvable granular formulation of baclofen.
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
Relapsing-Remitting MS Tied to Depression and Altered Attention Performance
Researchers sought to verify and analyze the relationship between symptoms of depression and attention performance in patients with multiple sclerosis.
Updated Guidelines on the Role of MRI in Multiple Sclerosis
Presenting at the CSMC 2021, researchers highlighted the international consensus 2021 revisions to the guidelines on MRI in multiple sclerosis (MS), merging recommendations from 3 MS groups.
FDA to Review sNDA for Purified Cortrophin Gel for Multiple Indications
Purified Cortrophin Gel is a purified adrenocorticotropic hormone.
Pregnancy in Women With MS Relapses in Year Before Conception Increases Disability Risk
Study researchers assessed the long-term disability risk following pregnancy in women with multiple sclerosis.
Many Patients With Multiple Sclerosis Harbor Misconceptions About Vaccinations
A team of researchers surveyed patients with multiple sclerosis to determine if influenza vaccine uptake would not meet public health targets.
The Changing Guidelines on the Role of MRI in Multiple Sclerosis Management
The 2021 MAGNIMS-CMSC-NAIMS provided updated consensus recommendations on MRI use in the management of multiple sclerosis.
Kappa-Free Light Chain Index Predicts Early Multiple Sclerosis Disease Activity
A team of investigators sought to determine whether κ- and λ-FLC index may predict early multiple sclerosis disease activity independent of demographics, clinical, and MRI characteristics.
- Loading...
Loading...
Loading... 
Loading...